Skip to content
beyondpositive
  • Home
  • News
  • About us
    • About us
    • Privacy Policy
  • Home
  • News
  • About us
    • About us
    • Privacy Policy
  • Twitter
  • facebook
  • insta
Donate
Twice-yearly lenacapavir 89% more effective than Truvada
Posted inNews PrEP Prevention Research

Twice-yearly lenacapavir 89% more effective than Truvada

Posted by By Tom Hayes-Isaacs 2024-09-24
New data from the PURPOSE 2 study shows that twice-yearly lenacapavir is 89% more effective…
Read More
An illustration of a strand of DNA being cut in half by silver scissors - representing the CRISPR gene editing technique.
Posted inConferences News Research Treatment

HIV viral rebounds following CRISPR gene therapy

Posted by By Tom Hayes-Isaacs 2024-08-06
EBT-101, a gene-editing therapy utilising CRISPR technology, showed promising safety and tolerability in an initial…
Read More

Recent Posts

  • Rising syphilis rates in West Midlands cause concern
  • Gilead to support generic lenacapavir in low-income nations
  • Activists demand global access to HIV prevention drug
  • Twice-yearly lenacapavir 89% more effective than Truvada
  • Concern as PrEP supplies run low in Australia

Categories

  • Campaigning
  • Community News
  • Conferences
  • Criminalisation
  • Cure
  • Events
  • Healthcare
  • Human Rights
  • International
  • Medicines
  • News
  • Parenting
  • PrEP
  • Prevention
  • Research
  • Sexual Health
  • Site News
  • Social Media
  • Stigma
  • Support
  • Treatment

beyondpositive is part of the Saving Lives UK family.
To find out more head to www.savinglivesuk.com

Copyright Saving Lives UK 2024

Scroll to Top